Treatment of refractory Tourette syndrome with haloperidol decanoate.
A 23-year-old male with a history of severe Tourette syndrome refractory to treatment with oral haloperidol is reported. The Tourette symptoms remitted after treatment with haloperidol decanoate. The response has been maintained over 18 months.
Clarke
D J
DJ
Department of Psychiatry, Queen Elizabeth Hospital, Birmingham, United Kingdom.
Ford
R
R
D000328:Adult; D006220:Haloperidol / Q000031:analogs & derivatives* / Q000627:therapeutic use; D006801:Humans; D008297:Male; D005879:Tourette Syndrome / Q000188:drug therapy*
C033563:haloperidol decanoate; D006220:Haloperidol